Evidence map›Paper›PMID 28485987›Full record

Trial reportThe American journal of drug and alcohol abuse2017

Assessing self-reported use of new psychoactive substances: The impact of gate questions.

Joseph J Palamar, Patricia Acosta, Fermín Fernández Calderón, Scott Sherman, Charles M Cleland

Open access · greenAbstract readRandomized Controlled Trial
In one paragraph

Trial report in The American journal of drug and alcohol abuse, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
2.5field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 26 citations in OpenAlex.

  1. Trial
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Barriers to accurately assessing prescription opioid misuse on surveys.The American journal of drug and alcohol abuse · 2019
    Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 2 countries.

Joseph J Palamara Department of Population Health , New York University Langone Medical Center , New York , NY , USA.
Patricia Acostaa Department of Population Health , New York University Langone Medical Center , New York , NY , USA.
Fermín Fernández Calderónc Department of Clinical , Experimental and Social Psychology, University of Huelva , Huelva , Spain.ORCID 0000-0002-2981-1670
Scott Shermana Department of Population Health , New York University Langone Medical Center , New York , NY , USA.
Charles M Clelandb Center for Drug Use and HIV Research , New York University Rory Meyers College of Nursing , New York , NY , USA.
NYU Langone Health · USNew York University · USUniversidad de Huelva · ES

Funding

Transdisciplinary Theoretical Svnthesis and Development CoreP30DA011041 · NIDA · NEW YORK UNIVERSITY · PI Holly Hagan · 1998 to 2026
$38.9M
Development of a Rapid Survey to Detect Use of New and Emerging DrugsK01DA038800 · NIDA · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI PALAMAR, JOSEPH J · 2015 to 2019
$879k
NIDA NIH HHS K01 DA038800NIDA NIH HHS P30 DA011041
6 · The paper itself

Abstract

backgroundNew psychoactive substances (NPS) continue to emerge; however, few surveys of substance use ask about NPS use. Research is needed to determine how to most effectively query use of NPS and other uncommon drugs.

objectiveTo determine whether prevalence of self-reported lifetime and past-year use differs depending on whether or not queries about NPS use are preceded by "gate questions." Gate questions utilize skip-logic, such that only a "yes" response to the use of specific drug class is followed by more extensive queries of drug use in that drug class.

methodsWe surveyed 1,048 nightclub and dance festival attendees (42.6% female) entering randomly selected venues in New York City in 2016. Participants were randomized to gate vs. no gate question before each drug category. Analyses focus on eight categories classifying 145 compounds: NBOMe, 2C, DOx, "bath salts" (synthetic cathinones), other stimulants, tryptamines, dissociatives, and non-phenethylamine psychedelics. Participants, however, were asked about specific "bath salts" regardless of their response to the gate question to test reliability. We examined whether prevalence of use of each category differed by gate condition and whether gate effects were moderated by participant demographics.

resultsPrevalence of use of DOx, other stimulants, and non-phenethylamine psychedelics was higher without a gate question. Gate effects for other stimulants and non-phenethylamine psychedelics were larger among white participants and those attending parties less frequently. Almost one in ten (9.3%) participants reporting no "bath salt" use via the gate question later reported use of a "bath salt" such as mephedrone, methedrone, or methylone.

conclusionOmitting gate questions may improve accuracy of data collected via self-report.

Indexed as

HallucinogensHealth SurveysIllicit DrugsSelf ReportAdolescentAdultData CollectionFemaleHumansMaleNew York CityReproducibility of ResultsSubstance-Related DisordersYoung AdultHallucinogensIllicit DrugsNew psychoactive substancesnightclub party attendeessurvey methodologysynthetic cathinones

Identifiers

PMID28485987
PMCPMC5660869
OpenAlexW2612760508

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.